Drug research: myths, hype and reality
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
Kelder, J., Grootenhuis, P. D. J., Bayada, D. M., Delbressine, L. P. C., & Ploemen, J.-P. (1999) · Pharmaceutical Research · doi:10.1023/a:1015040217741 · Cited by 813
Is There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769
The Practice of Medicinal Chemistry
(2003) · Elsevier eBooks · doi:10.1016/b978-0-12-744481-9.x5000-4 · Cited by 702
The Double Helix: A Personal Account of the Discovery of the Structure of DNA
Watson, J. D., & Devons, S. (1968) · Physics Today · doi:10.1063/1.3035117 · Cited by 638
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
Managing the drug discovery/development interface
Kennedy, T. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01099-4 · Cited by 522
Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?
Ajay, Walters, W. P., & Murcko, M. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970666c · Cited by 484 · cited 1×
“'Drug-like' or 'non-drug-like' character should be decided by other methods, for example, by neural net”
MethodPharmaceutical innovation by the seven UK‐owned pharmaceutical companies (1964‐1985).
Prentis, R., Lis, Y., & Walker, Sr. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb03318.x · Cited by 471
VolSurf: a new tool for the pharmacokinetic optimization of lead compounds
Cruciani, G., Pastor, M., & Guba, W. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00162-7 · Cited by 419
A Scoring Scheme for Discriminating between Drugs and Nondrugs
Sadowski, J., & Kubinyi, H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9706776 · Cited by 392
Self-citationThe Practice of Medicinal Chemistry
(2015) · Elsevier eBooks · doi:10.1016/c2012-0-03066-9 · Cited by 383
Drugs, leads, and drug-likeness: an analysis of some recently launched drugs
Proudfoot, J. R. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00244-5 · Cited by 252
Horrobin, D. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1012 · Cited by 248
Absorption Classification of Oral Drugs Based on Molecular Surface Properties
Bergström, C. A. S., Strafford, M., Lazorova, L., Avdeef, A., Luthman, K., & Artursson, P. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020986i · Cited by 247
Hydrogen bonding of carbonyl, ether, and ester oxygen atoms with alkanol hydroxyl groups
Lommerse, J. P. M., Price, S. L., & Taylor, R. (1997) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(19970430)18:6<757::aid-jcc3>3.0.co;2-r · Cited by 225
Testa, B., Krämer, S. D., Wunderli‐Allenspach, H., & Folkers, G. (2006) · Cited by 166
Strategic trends in the drug industry
Drews, J. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02690-4 · Cited by 165
Lahana, R. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01393-8 · Cited by 160
Drug prototypes and their exploitation
(1997) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(97)84366-8 · Cited by 147
Oxygen and Nitrogen in Competitive Situations: Which is the Hydrogen‐Bond Acceptor?
Böhm, H., Brode, S., Hesse, U., & Klebe, G. (1996) · Chemistry - A European Journal · doi:10.1002/chem.19960021206 · Cited by 107
Drug prototypes and their exploitation
(1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(97)90084-7 · Cited by 78
Hydrogen Bonding: The Last Mystery in Drug Design?
Kubinyi, H. (2001) · doi:10.1002/9783906390437.ch28 · Cited by 56
Self-citation
Research works printed but not linked: 1
- Watson, J. D., with Berry, A. DNA. The Secret of Life. (William Heinemann, London, 2003).
Cited by
A BOILED‐Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules
Daina, A., & Zoete, V. (2016) · ChemMedChem · doi:10.1002/cmdc.201600182 · Cited by 2,549
Multi-target therapeutics: when the whole is greater than the sum of the parts
Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105
Vishwanathan, S. V. N., Schraudolph, N. N., Kondor, R., & Borgwardt, K. M. (2010) · CaltechAUTHORS (California Institute of Technology) · Cited by 1,305
Combining docking and molecular dynamic simulations in drug design
Alonso, H., Bliznyuk, A. A., & Gready, J. E. (2006) · Medicinal Research Reviews · doi:10.1002/med.20067 · Cited by 759
Halogen atoms in the modern medicinal chemistry: hints for the drug design
Hernandes, M., Cavalcanti, S. M., Moreira, D. R., de Azevedo Junior, W., & Leite, A. C. (2010) · Current Drug Targets · doi:10.2174/138945010790711996 · Cited by 723
Metadata
- Authors
- Kubinyi, H.
- Corresponding author
- Kubinyi, Hugo
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-08
- Volume
- 2
- Issue
- 8
- Pages
- 665-668
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1487233798
- Cited by
- 348
- References
- 32
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 13 · 2023: 6 · 2022: 9 · 2021: 4 · 2020: 9 · 2019: 16 · 2018: 24 · 2017: 8 · 2016: 15 · 2015: 17 · 2014: 16 · 2013: 17 · 2012: 26
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Keywords
- drug discovery, lead-like compounds, drug-like molecules, oral bioavailability, combinatorial chemistry, high-throughput screening, ADME, computer-aided drug design, structure-based drug design, lead optimization, medicinal chemistry
- MeSH terms
- Chemistry, Pharmaceutical, Humans, Pharmacokinetics, Pharmacology, Research, Technology, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.